阿尔茨海默病的特异性转录组和表观组变化,在托的催化途径
Kyonghwan Choe1, Muhammad Ali1,2,3, Roy Lardenoije1,4
1Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences (FHML), Mental Health and Neuroscience Research Institute (MHeNs) and European Graduate School of Neuroscience (EURON), Maastricht University, Maastricht, 6211 LK, the Netherlands.
Alzheimer's research & therapy
|November 30, 2024
概括
阿尔茨海默病在基因表达和表观遗传层面上都显示出托和NAD途径的显著变化. 免疫基因IDO2被确定为进一步阿尔茨海默氏症研究的关键候选者.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 像阿尔茨海默氏症 (AD) 这样的神经退行性疾病与改变的托 (TRP) 代谢有关.
- 之前的研究还没有系统地研究在AD的转录和表观遗传水平上TRP途径的变化.
- 这项研究通过检查AD中的TRP和尼古丁胺胺氨基二核酸 (NAD) 途径来弥补这一差距.
研究的目的:
- 调查阿尔茨海默病中TRP和NAD通路基因的转录基因,DNA甲基 (5mC) 和基甲基 (5hmC) 变化.
- 识别AD病原体的关键基因和分子机制.
- 探索潜在的新生物标志物和AD的治疗点.
主要方法:
- 从死后的大脑组织 (中环) 和来自三个独立队伍 (AD患者和对照组) 的血液样本中获取的DNA分析.
- 使用mRNA表达和DNA (基) 甲基化阵列 (HumanHT-12 v4和HM 450K BeadChip) 的分子分析.
- 计算建模包括基因调节网络 (GRN) 和网络扰动分析,在 IDO2.2 中对特定 CpG 位点甲基化进行 pyrosequencing.
主要成果:
- 在AD大脑中的12个TRP和20个NAD相关基因中观察到差异性基因表达.
- 在mRNA表达水平上,在kynurenine和NAD通路中的基因组的丰富.
- IDO2,一种免疫调节基因,通过综合数据分析被确定为AD的关键候选者;在AD转换器和非转换器之间在特定的IDO2CpG位点发现了显著的甲基化差异.
结论:
- 在阿尔茨海默病中,TRP和NAD路径相关基因的大量转录和表观遗传变化是显而易见的.
- IDO2成为一个关键的候选基因,需要在AD中进一步调查.
- 这些与途径相关的基因及其蛋白质代表了潜在的新生物标志物和AD的治疗点.
相关概念视频
01:26Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
01:29Amino Acid Biosynthetic Pathways
3
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
3
02:42Transcription Attenuation in Prokaryotes
15.1K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
15.1K
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165